Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Alcohol Clin Exp Res. 2016 Feb 9;40(3):563–571. doi: 10.1111/acer.12972

Table 1.

Summary of the effects of fenofibrate and tesaglitazar in male and female B6 and B6 × 129S4 mice.

Test Males Females
Treatment Fenofibrate
(150 mg/kg)
Tesaglitazar
(1.5 mg/kg)
Fenofibrate
(150 mg/kg)
Tesaglitazar
(1.5 mg/kg)
Genotype B6 × 129 B6 B6 × 129 B6 B6 B6
2BC
(saccharin)
Preference = = = =
Total intake = = =
CPP Acquisition = =
Novelty = =
CTA Acquisition = =
Acute
withdrawal
Above
basal
= =
Below
basal
=
Startle
response
=
LORR
Metabolism Clearance =
2BC –
continuous
Ethanol
(g/kg/24h)
↓↓ ↓↓↓ =
Preference ↓↓ ↓↓↓ =
Total fluid
intake
(g/kg/24h)
= ↑↑ =
2BC –
intermittent
Ethanol
(g/kg/24h)
Preference
Total fluid
intake
(g/kg/24h)
= =

2BC, two-bottle choice; CPP, conditioned place preference; CTA, conditioned taste aversion; LORR, loss or righting reflex; =, ↓, ↑ indicate no change, decrease, or increase compared to control. Data from 2BC-continuous and 2BC-intermittent drinking are from the companion manuscript (Blednov et al., in press.).

HHS Vulnerability Disclosure